[1]
“Potential benefits of novel agent Tanshinone in the management of oral submucous fibrosis”, J Orofac Res, vol. 9, no. 2, pp. 20–23, May 2020, Accessed: Oct. 02, 2024. [Online]. Available: https://mansapublishers.com/index.php/jofr/article/view/2321